Bibliographie (2530)
CDC Report: Unvaccinated 5 times more likely to get COVID-19 and 29 times more likely to be hospitalized than vaccinated individuals.
mercredi, 25 août 2021 13:49 Écrit par Zouhair SouissiSARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021 – CDC Morbidity and Mortality Weekly Report Commentary: CDC: Unvaccinated 5 times more likely to get COVID-19 – CIDRAP Commentary on Twitter A new CDC study finds that while the #DeltaVariant surged in […]
The post CDC Report: Unvaccinated 5 times more likely to get COVID-19 and 29 times more likely to be hospitalized than vaccinated individuals. appeared first on Links Medicus.
COVID vaccines protect against Delta, but their effectiveness wanes.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiCOVID vaccines protect against Delta, but their effectiveness wanes – Nature Original study: [Preprint] Pfizer vaccine effectiveness against Delta declines faster than AstraZeneca, both offering the same protection after 4 months.
The post COVID vaccines protect against Delta, but their effectiveness wanes. appeared first on Links Medicus.
How I Do It: Considering lung transplantation for patients with COVID-19.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiHow I Do It: Considering lung transplantation for patients with COVID-19 – CHEST Related: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries Report: Lung transplantation for 3 patients with severe COVID-19
The post How I Do It: Considering lung transplantation for patients with COVID-19. appeared first on Links Medicus.
M-A: Patient–ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiPatient–ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions: a systematic review and meta-analysis – Journal of Intensive Care
The post M-A: Patient–ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions. appeared first on Links Medicus.
Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiThe FDA Really Did Have to Take This Long – The Atlantic
The post Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”. appeared first on Links Medicus.
How will Delta evolve? Here’s what the theory tells us.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiHow will Delta evolve? Here’s what the theory tells us – The Conversation
The post How will Delta evolve? Here’s what the theory tells us. appeared first on Links Medicus.
![[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.](/media/k2/items/cache/2cd457d9d226bd83dc78b3603c1a8fd0_S.jpg)
[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiRCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials Related: Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine). Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19 Commentary […]
The post [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19. appeared first on Links Medicus.
Covid-19 booster vaccines: What we know and who’s doing what.
mardi, 24 août 2021 12:52 Écrit par Zouhair SouissiCovid-19 booster vaccines: What we know and who’s doing what – The BMJ
The post Covid-19 booster vaccines: What we know and who’s doing what. appeared first on Links Medicus.
Study Commentaries: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial.
lundi, 23 août 2021 05:14 Écrit par Zouhair SouissiCommentary 1: JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial – St Emlyn’s Commentary 2: An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 – The Bottom Line Original study: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP […]
The post Study Commentaries: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. appeared first on Links Medicus.
Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies.
lundi, 23 août 2021 05:14 Écrit par Zouhair SouissiSafety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study – The Lancet Respiratory Medicine Invited Commentary: Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19 Related: Lab study shows heterologous AstraZeneca/Pfizer vaccination produces strong immune response against SARS-CoV-2 Delta variant. RCT: Safety and immunogenicity of heterologous […]
The post Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies. appeared first on Links Medicus.
![[Preprint] Study shows symptomatic breakthrough infections are probably less transmissible than SARS-CoV-2 infections in unvaccinated individuals.](/media/k2/items/cache/fb2f4dce862da1bee62f9456b87d8a12_XS.jpg)
